Trademarkia Logo

Australia

AU$
Trademark Search
LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES

View On IPO.GOV.AU

LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES
Ceased - Not renewed: Renewal fee not paid

Last updated on 13 Oct 2016

Owner Info

Novo Nordisk A/S

Novo Alle

DK-2880 Bagsvaerd, DENMARK

Serial Number

1126115 filed on 7 Mar 2006

Correspondent

Novo Nordisk A/S Corporate Trademarks

Novo Alle,

DK-2880 Bagsvaerd,

DENMARK

LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES

Classification Information

Class [016]
Printed publications related to medical studies and research regarding pharmaceutical preparations for the treatment of diabetes related diseases and Read More

Class [042]
Medical and scientific research, namely, conducting clinical trials and studies for pharmaceutical preparations related to the treatment of diabetes r Read More

Class [044]
Providing medical information on the efficacy of pharmaceutical preparations for the treatment of diabetes related diseases and disorders

Mark Details

Serial Number

1126115

Registered On

7 Mar 2006

Renewal On

NA

Mark Type

FANCY

Priority Claim (Convention Details)

Date

22 Nov 2005

Mark Type

DK

Legal History

Show more

Status DateAction Taken
13th Oct 2016Trade Marks Removed from Register Published
11th Oct 2016Remove Trade Mark Non-Payment Renewal
6th Oct 2016General Correspondence (Application or Registration)
21st Mar 2016Registration Status Change
7th Sept 2015Registration Status Change
14th Dec 2006IP Right Registration Published
27th Nov 2006Application Status
27th Nov 2006Register Trade Mark
17th Aug 2006IP Right Acceptance Published
17th Aug 2006IP Right Filed Published